|Positive WB detected in||human plasma tissue, human lung tissue|
|Positive IHC detected in||human tonsillitis tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive IF detected in||human tonsillitis tissue|
|Western Blot (WB)||WB : 1:500-1:2000|
|Immunohistochemistry (IHC)||IHC : 1:5000-1:20000|
|Immunofluorescence (IF)||IF : 1:200-1:800|
|Sample-dependent, check data in validation data gallery|
11449-1-AP targets Human IgA Heavy Chain in WB, IHC, IF,ELISA applications and shows reactivity with human samples.
|Cited Reactivity||human, mouse, pig|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Human IgA Heavy Chain fusion protein Ag2007|
|Full Name||immunoglobulin heavy constant alpha 1|
|Calculated molecular weight||496 aa, 53 kDa|
|Observed molecular weight||53 kDa|
|GenBank accession number||BC016369|
|Gene ID (NCBI)||3493|
|Purification Method||Antigen affinity purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
Ig alpha is the major immunoglobulin class in body secretions. It may serve both to defend against local infection and to prevent access of foreign antigens to the general immunologic system. This antibody recognizes the Chain C region of human Ig alpha-1 (IGHA1).
|Product Specific Protocols|
|WB protocol for Human IgA Heavy Chain antibody 11449-1-AP||Download protocol|
|IHC protocol for Human IgA Heavy Chain antibody 11449-1-AP||Download protocol|
|IF protocol for Human IgA Heavy Chain antibody 11449-1-AP||Download protocol|
|Click here to view our Standard Protocols|
Anim Sci J
Effects of 7S and 11S on the intestine of weaned piglets after injection and oral administration of soybean antigen protein.
Altered microbial community structure in PI3Kγ knockout mice with colitis impeding relief of inflammation: Establishment of new indices for intestinal microbial disorder.
Immune responses and residual SARS-CoV-2 in two critically ill COVID-19 patients before and after lung transplantation.